Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Peloton Interactive Inc (PTON) vs Stryker Corporation (SYK) Price & Performance

Peloton Interactive IncTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Peloton Interactive Inc vs Stryker Corporation — how do they compare? Peloton Interactive Inc trades at $4.91 (market cap $2.16B), while Stryker Corporation trades at $276.85 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 49.2× Peloton Interactive Inc's market cap, and Stryker Corporation pays a 1.27% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Peloton Interactive Inc for 37 Days and Stryker Corporation for 20 Days on average.

PTONSYK
Market Cap
$2.16B$106.24B
Volume
11,369,4872,982,001
Sector
Consumer CyclicalHealth
52-Week High
$7.86$388.35
52-Week Low
$3.71$269.75
Typical Hold Time
37 Days20 Days
Enterprise Value
$2.66B$117.70B
Dividend Yield
—1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Peloton Interactive Inc

Peloton (PTON) trades at $4.85, down 0.41% on the day, as the stock remains under technical pressure with bearish moving average signals. Fundamentally, the company achieved its first full-year net profit in fiscal 2026 with a 2.58% margin, while revenue declined to $2.4B. Recent product launches include a new foldable Tread Flex treadmill and AI-powered coaching features, signaling continued turnaround efforts under CEO Peter Stern's leadership.

The outlook remains challenged despite profitability improvements, with analyst consensus pointing to significant upside (target $8.00) but technical weakness and declining subscriber counts creating headwinds. Key risks include execution of the turnaround strategy, competitive pressure in connected fitness, and high debt levels, though cost-cutting measures show early success.

Stryker Corporation

Stryker (SYK) trades at $275.4, down 1.11% amid a bearish technical signal and negative news flow. The company maintains strong profitability with a 14.43% net margin and a 71% analyst buy rating, but faces headwinds from a manufacturing issue disclosure that triggered an 8.8% stock drop on September 8, 2026. Q3 2026 earnings are due October 29, 2026, following a mixed earnings history with a recent miss in Q1 2026.

The stock presents a divergence between solid fundamentals and near-term sentiment risks. The consensus price target of $368.11 implies significant upside, but ongoing legal investigations and operational challenges pose risks to investor confidence. Earnings growth and resolution of manufacturing issues are critical for sustained recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PTON

No sentiment data available yet.

SYK
1% Buy99% Sell
Avg holding period · 20 Days

Top news

Latest headlines on both assets

About Peloton Interactive Inc

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.

Read more on PTON →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →